GO:0051598 meiotic recombination checkpoint signaling: Pachytene Checkpoint Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051598 (meiotic recombination checkpoint signaling) is the signaling process that delays exit from pachytene until meiotic recombination intermediates are resolved, preventing premature segregation of homologous chromosomes.
• The checkpoint is built on conserved sensor, transducer and effector modules, including ATM/ATR orthologs, the 9-1-1 clamp, Ddc2/ATRIP, CHK kinases and Pch2/TRIP13.
• In budding yeast, the meiotic recombination checkpoint requires mitotic checkpoint genes such as RAD17, RAD24, MEC1, RAD53 and PDS1, showing that meiotic and mitotic surveillance share core machinery.
• The checkpoint also prevents DNA rereplication during meiotic prophase, coupling recombination surveillance to replication licensing control.
• A Piezo-dependent checkpoint at the oocyte nuclear envelope links mechanical/cytoplasmic signals to meiotic progression in mouse oocytes.
• Defects in meiotic recombination checkpoint signaling cause chromosome missegregation, aneuploidy, infertility and are mechanistically relevant to cancer-prone genome instability.
Description
Meiosis is the specialized cell division that halves the chromosome number to produce gametes, and its success depends on the precise completion of homologous recombination during prophase I. GO:0051598, meiotic recombination checkpoint signaling, is the surveillance pathway that monitors recombination intermediates in late prophase I (pachytene) and blocks the onset of chromosome segregation until recombination is complete. This checkpoint ensures that each pair of homologous chromosomes is properly connected and that genetic material is distributed accurately to the gametes. The pathway is conserved from yeast to mammals and shares sensor and effector modules with the DNA damage response, including ATM/ATR-related kinases, the 9-1-1 clamp, Ddc2/ATRIP, CHK kinases and Pch2/TRIP13. In budding yeast, the meiotic recombination checkpoint depends on mitotic checkpoint genes such as RAD17, RAD24, MEC1, RAD53 and PDS1, demonstrating that meiotic surveillance reuses canonical checkpoint components. The Ddc2/ATRIP checkpoint protein monitors meiotic recombination intermediates and is required for checkpoint arrest in response to unrepaired double-strand breaks. Pch2, an AAA+ ATPase, has a nucleolar-independent role in the meiotic recombination checkpoint and localizes to meiotic chromosomes in a manner controlled by checkpoint signals. The checkpoint also prevents DNA rereplication during meiotic prophase, linking recombination surveillance to replication licensing. More recently, a Piezo-dependent checkpoint at the oocyte nuclear envelope has been shown to couple mechanical or cytoplasmic signals to meiotic progression in mouse oocytes. For researchers, GO:0051598 is a tractable entry point to study how cells coordinate recombination, cell-cycle progression and gamete quality, and how failures in this coordination contribute to aneuploidy, infertility and genome instability.
meiotic recombination checkpoint signaling At A Glance
| GO ID | GO:0051598 |
|---|---|
| GO term | meiotic recombination checkpoint signaling |
| Ontology | biological_process |
| Synonym | meiotic recombination checkpoint; pachytene checkpoint; signal transduction involved in meiotic recombination checkpoint |
| Definition | A signaling process that contributes to a meiotic recombination checkpoint, that acts during late prophase I (pachytene) and prevents segregation of homologous chromosomes until recombination is completed, ensuring proper distribution of the genetic material to the gametes. |
| Major function | Monitors recombination intermediates and delays meiotic progression until recombination is complete, preventing chromosome missegregation. |
| Timing | Late prophase I (pachytene). |
| Conserved machinery | ATM/ATR-related kinases, 9-1-1 clamp, Ddc2/ATRIP, CHK kinases, Pch2/TRIP13. |
| Related process | DNA damage response, meiotic cell cycle control, prevention of DNA rereplication. |
What Is GO:0051598?
GO:0051598, meiotic recombination checkpoint signaling, is defined as a signaling process that contributes to a meiotic recombination checkpoint, acting during late prophase I (pachytene) and preventing segregation of homologous chromosomes until recombination is completed, thereby ensuring proper distribution of the genetic material to the gametes. In practice, this means that when recombination intermediates or unrepaired double-strand breaks persist in pachytene, the checkpoint generates a signal that delays meiotic progression, allowing repair and crossover formation to finish before the first meiotic division. The term is a biological process and is synonymous with meiotic recombination checkpoint, pachytene checkpoint, and signal transduction involved in meiotic recombination checkpoint.
Why Is meiotic recombination checkpoint signaling Important in Cell Biology?
Meiotic recombination checkpoint signaling is essential because it couples the completion of recombination to the irreversible decision to segregate homologous chromosomes. Without this checkpoint, cells can enter division with unrepaired breaks or unresolved recombination intermediates, leading to chromosome missegregation, aneuploidy and gamete inviability. The pathway is also a paradigm for understanding how cells integrate DNA damage signals with developmental cell-cycle transitions, and it shares core components with the mitotic DNA damage checkpoint, making it a valuable model for conserved surveillance mechanisms. In budding yeast, the checkpoint requires mitotic checkpoint genes such as RAD17, RAD24, MEC1, RAD53 and PDS1, showing that meiotic surveillance is built on canonical checkpoint modules. Ddc2/ATRIP monitors meiotic recombination intermediates and is required for checkpoint arrest, providing a direct link between recombination intermediates and checkpoint activation. Pch2 has a nucleolar-independent role in the meiotic recombination checkpoint, highlighting specialized regulation of the pathway. The checkpoint also prevents DNA rereplication during meiotic prophase, revealing an unexpected connection between recombination surveillance and replication control. In mouse oocytes, a Piezo-dependent checkpoint at the nuclear envelope links mechanical or cytoplasmic signals to meiotic progression, expanding the signaling inputs that can influence this checkpoint. Clinically, defects in meiotic recombination checkpoint signaling are associated with infertility, aneuploidy and genome instability, and the pathway is relevant to cancer biology because many checkpoint components are tumor suppressors or oncogenes.
• Prevents premature segregation of homologous chromosomes until recombination is completed.
• Protects against aneuploidy and chromosome missegregation in gametes.
• Shares core machinery with the mitotic DNA damage checkpoint, including RAD17, RAD24, MEC1, RAD53 and PDS1 in budding yeast.
• Ddc2/ATRIP monitors meiotic recombination intermediates and is required for checkpoint arrest.
• Pch2 has a nucleolar-independent role in the meiotic recombination checkpoint.
• The checkpoint prevents DNA rereplication during meiotic prophase.
• A Piezo-dependent checkpoint at the oocyte nuclear envelope links mechanical signals to meiotic progression.
• Defects are linked to infertility, aneuploidy and genome instability.
• Provides a model for understanding how cells coordinate recombination with cell-cycle transitions.
• Relevant to cancer biology because many checkpoint components are tumor suppressors or oncogenes.
What Happens During meiotic recombination checkpoint signaling?
Sensing recombination intermediates in pachytene
In simple terms: The cell checks whether recombination is finished before it divides.
During late prophase I (pachytene), the meiotic recombination checkpoint monitors recombination intermediates and unrepaired double-strand breaks. Sensor modules, including the 9-1-1 clamp and Ddc2/ATRIP, recognize recombination intermediates and recruit apical kinases related to ATM/ATR. In budding yeast, this sensing requires mitotic checkpoint genes such as RAD17, RAD24 and MEC1, demonstrating that meiotic surveillance reuses canonical DNA damage sensor modules. Ddc2/ATRIP is specifically required to monitor meiotic recombination intermediates and to trigger checkpoint arrest when breaks persist.
Signal transduction to cell-cycle effectors
In simple terms: The checkpoint sends a stop signal to the cell-cycle engine.
Once sensors detect recombination intermediates, the signal is transduced through checkpoint kinases such as CHK kinases and, in budding yeast, RAD53. This signaling ultimately delays progression to the first meiotic division by inhibiting the machinery that drives chromosome segregation. The meiotic recombination checkpoint network operates step-by-step through meiotic prophase, integrating signals from recombination, chromosome structure and cell-cycle regulators. Phospho-regulation of meiotic prophase proteins is a central mechanism by which the checkpoint controls timing and substrate specificity.
Pch2/TRIP13 and specialized checkpoint regulation
In simple terms: A specialized ATPase fine-tunes the checkpoint.
Pch2, an AAA+ ATPase orthologous to TRIP13, has a nucleolar-independent role in the meiotic recombination checkpoint and localizes to meiotic chromosomes in a manner controlled by checkpoint signals. Pch2/TRIP13 is implicated in remodeling recombination and checkpoint complexes, and its localization determinants reveal how the checkpoint is spatially organized within the nucleus. This specialization allows the meiotic checkpoint to respond to recombination intermediates while avoiding inappropriate activation by other DNA structures.
Prevention of DNA rereplication during meiotic prophase
In simple terms: The checkpoint also stops the cell from copying its DNA again.
The meiotic recombination checkpoint prevents DNA rereplication during meiotic prophase, coupling recombination surveillance to replication licensing control. This function ensures that the genome is replicated exactly once before meiosis and that rereplication does not interfere with recombination or chromosome segregation. The finding that a meiotic recombination checkpoint response prevents rereplication highlights the breadth of checkpoint outputs beyond simple cell-cycle delay.
Nuclear envelope and mechanical inputs in oocytes
In simple terms: In oocytes, the checkpoint can also respond to mechanical signals at the nuclear envelope.
A Piezo-dependent checkpoint at the oocyte nuclear envelope links mechanical or cytoplasmic signals to meiotic progression in mouse oocytes. Chemically induced proximity revealed this Piezo-dependent meiotic checkpoint, showing that the nuclear envelope can act as a signaling platform for meiotic surveillance. This expands the inputs to meiotic recombination checkpoint signaling beyond DNA damage alone, integrating mechanical and developmental cues.
Key Genes Involved in GO:0051598 meiotic recombination checkpoint signaling
The genes and proteins below are core components or regulators of meiotic recombination checkpoint signaling, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MEC1 | Apical kinase required for meiotic recombination checkpoint in budding yeast | Genetic dissection of checkpoint activation |
| RAD17 | Checkpoint clamp loader component required for meiotic recombination checkpoint | Sensor module studies |
| RAD24 | Checkpoint clamp loader component required for meiotic recombination checkpoint | Sensor module studies |
| RAD53 | Effector kinase required for meiotic recombination checkpoint | Signal transduction studies |
| PDS1 | Downstream effector required for meiotic recombination checkpoint | Cell-cycle arrest studies |
| DDC2 | ATRIP ortholog that monitors meiotic recombination intermediates | Intermediate sensing studies |
| PCH2 | AAA+ ATPase with nucleolar-independent role in meiotic recombination checkpoint | Localization and regulation studies |
| TRIP13 | Vertebrate Pch2 ortholog implicated in meiotic checkpoint regulation | Translational studies |
| ATM | Apical kinase related to meiotic checkpoint signaling | Conserved signaling studies |
| ATR | Apical kinase related to meiotic checkpoint signaling | Conserved signaling studies |
| CHK1 | Effector kinase in checkpoint signaling | Phospho-regulation studies |
| CHK2 | Effector kinase in checkpoint signaling | Phospho-regulation studies |
| HOP1 | Meiotic chromosome axis protein linked to checkpoint signaling | Axis function studies |
| ZIP1 | Synaptonemal complex protein linked to checkpoint signaling | Synapsis studies |
| DMC1 | Meiotic recombinase whose intermediates are monitored | Recombination studies |
| SPO11 | Meiotic double-strand break inducer whose products are monitored | Break formation studies |
| PIEZO1 | Mechanosensitive channel linked to oocyte nuclear envelope checkpoint | Mechanical checkpoint studies |
How Is meiotic recombination checkpoint signaling Regulated?
Meiotic recombination checkpoint signaling is regulated at multiple levels. Phospho-regulation of meiotic prophase proteins controls the timing and substrate specificity of checkpoint kinases. In budding yeast, the checkpoint requires mitotic checkpoint genes such as RAD17, RAD24, MEC1, RAD53 and PDS1, showing that regulation is shared with the DNA damage response. Ddc2/ATRIP monitors meiotic recombination intermediates and is required for checkpoint arrest, providing a direct link between recombination intermediates and checkpoint activation. Pch2/TRIP13 has a nucleolar-independent role in the meiotic recombination checkpoint, and its localization is controlled by checkpoint signals, adding a specialized layer of regulation. The checkpoint also prevents DNA rereplication during meiotic prophase, linking recombination surveillance to replication licensing control. In mouse oocytes, a Piezo-dependent checkpoint at the nuclear envelope links mechanical or cytoplasmic signals to meiotic progression, showing that the pathway integrates mechanical inputs. The meiotic checkpoint network operates step-by-step through meiotic prophase, integrating signals from recombination, chromosome structure and cell-cycle regulators.
meiotic recombination checkpoint signaling and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MEC1 | Meiotic checkpoint failure and aneuploidy | Yeast knockout and point-mutation models |
| DDC2 | Defective monitoring of recombination intermediates | Yeast knockout and tagged knock-in |
| PCH2 | Meiotic recombination checkpoint defects | Yeast knockout and localization studies |
| TRIP13 | Meiotic checkpoint regulation in vertebrates | Mammalian knockout and overexpression |
| PIEZO1 | Oocyte nuclear envelope checkpoint defects | Mouse oocyte knockout and knock-in |
Aneuploidy and infertility
Defects in meiotic recombination checkpoint signaling cause chromosome missegregation and aneuploidy, which are major causes of infertility and pregnancy loss. The checkpoint ensures that homologous chromosomes are properly connected before segregation, and its failure allows cells to divide with unresolved recombination intermediates. In mouse oocytes, a Piezo-dependent checkpoint at the nuclear envelope links mechanical signals to meiotic progression, and disruption of such checkpoint inputs can affect oocyte quality.
Cancer and genome instability
Many components of meiotic recombination checkpoint signaling are shared with the DNA damage response, including ATM/ATR-related kinases and CHK kinases, which are tumor suppressors or oncogenes. Loss of checkpoint function can promote genome instability, a hallmark of cancer. The finding that the meiotic recombination checkpoint prevents DNA rereplication further links checkpoint failure to replication stress and genome instability.
Developmental and reproductive disorders
Because the checkpoint acts during late prophase I (pachytene), its dysfunction can impair gamete formation and cause reproductive disorders. Pch2/TRIP13, a specialized checkpoint regulator, has a nucleolar-independent role in the meiotic recombination checkpoint, and its misregulation may contribute to meiotic defects. Ddc2/ATRIP is required to monitor meiotic recombination intermediates, and its loss leads to checkpoint failure and meiotic progression with unrepaired breaks.
From meiotic recombination checkpoint signaling-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for meiotic recombination checkpoint signaling? | Knockout cell model |
| Does a specific residue control checkpoint kinase activity? | Point-mutation knock-in |
| Where does a checkpoint protein localize during pachytene? | Tagged knock-in |
| Does overexpression of a checkpoint regulator delay meiotic progression? | Overexpression cell model |
| Which genes modify the meiotic recombination checkpoint? | CRISPR library screening |
| How does a mechanical signal activate the oocyte checkpoint? | Piezo-dependent oocyte model |
How to Study the meiotic recombination checkpoint signaling Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Yeast genetics | Requirement of checkpoint genes for meiotic arrest | Gene function studies |
| Tagged knock-in imaging | Localization of checkpoint proteins | Pch2 chromosome localization |
| Phospho-proteomics | Kinase substrates and signaling events | Mapping checkpoint phospho-regulation |
| CRISPR library screening | Genes modifying checkpoint signaling | Discovery of new regulators |
| Oocyte live imaging | Nuclear envelope checkpoint dynamics | Piezo-dependent checkpoint studies |
| Recombination intermediate assays | Persistence of meiotic recombination intermediates | Ddc2/ATRIP function |
| Rereplication assays | Prevention of DNA rereplication | Checkpoint output studies |
| Aneuploidy assays | Chromosome missegregation | Disease relevance studies |
Genetic dissection in yeast
Budding yeast is a powerful system for studying meiotic recombination checkpoint signaling because mitotic checkpoint genes such as RAD17, RAD24, MEC1, RAD53 and PDS1 are required for the meiotic checkpoint. Knockout and point-mutation alleles allow researchers to test which modules are essential for checkpoint arrest. Ddc2/ATRIP function can be probed by monitoring meiotic recombination intermediates and checkpoint arrest.
Imaging and localization studies
Tagged knock-in approaches allow visualization of checkpoint proteins such as Pch2 at meiotic chromosomes, revealing nucleolar-independent roles and localization determinants. Live-cell imaging in mouse oocytes can reveal nuclear envelope checkpoint dynamics and Piezo-dependent signaling. These methods connect checkpoint signaling to chromosome structure and nuclear architecture.
Phospho-proteomics and signaling assays
Phospho-regulation of meiotic prophase proteins is a central mechanism of checkpoint control, and phospho-proteomics can identify substrates of checkpoint kinases. Kinase assays and phospho-specific antibodies can test whether ATM/ATR-related kinases and CHK kinases are active during pachytene. These approaches define the signaling cascade from sensors to effectors.
Functional genomics and screening
CRISPR library screening can identify genes that modify meiotic recombination checkpoint signaling and its outputs, including prevention of DNA rereplication. The meiotic checkpoint network operates step-by-step through meiotic prophase, and functional genomics can map its genetic interactions. Such screens can reveal new regulators of aneuploidy and genome instability.
How CRISPR Can Be Used to Study GO:0051598 meiotic recombination checkpoint signaling
Knockout
CRISPR knockout of checkpoint genes such as MEC1, RAD17, RAD24, RAD53 or PDS1 in yeast can test their requirement for meiotic recombination checkpoint signaling. Knockout of DDC2 can reveal its role in monitoring meiotic recombination intermediates. Knockout of PCH2 can uncover its nucleolar-independent role in the checkpoint.
Point Mutation
Point-mutation knock-in can test whether specific residues in checkpoint kinases or effectors are required for signaling. Phospho-regulation of meiotic prophase proteins is a central mechanism, so phospho-site mutations can reveal regulatory nodes. Such models help distinguish catalytic from scaffolding functions.
Knock-in
Tagged knock-in of checkpoint proteins such as Pch2 allows localization studies at meiotic chromosomes. Knock-in of reporters can monitor checkpoint activation in live cells. These models connect signaling to chromosome structure and nuclear envelope dynamics.
Overexpression
Overexpression of checkpoint regulators can test whether increased signaling delays meiotic progression. Overexpression of Pch2 or its orthologs can reveal dominant effects on checkpoint activity. Such models complement loss-of-function studies to define pathway logic.
How EDITGENE Supports meiotic recombination checkpoint signaling Research
Researchers studying meiotic recombination checkpoint signaling-related genes often need to determine whether a candidate gene is causally involved in checkpoint control, and whether its function depends on specific residues, localization or expression levels. EDITGENE provides end-to-end CRISPR services to build precisely the models required for these questions.
Contact EDITGENE today to design your custom CRISPR model for meiotic recombination checkpoint signaling research.
Frequently Asked Questions About meiotic recombination checkpoint signaling
What is meiotic recombination checkpoint signaling?
It is the signaling process (GO:0051598) that acts during late prophase I (pachytene) and prevents segregation of homologous chromosomes until recombination is completed, ensuring proper distribution of genetic material to the gametes.
What genes are involved in meiotic recombination checkpoint signaling?
Core genes include MEC1, RAD17, RAD24, RAD53, PDS1, DDC2, PCH2 and TRIP13, as well as ATM/ATR-related kinases and CHK kinases.
Why is the pachytene checkpoint important?
It prevents chromosome missegregation and aneuploidy by delaying meiotic progression until recombination intermediates are resolved.
How does Ddc2/ATRIP function in the meiotic checkpoint?
Ddc2/ATRIP monitors meiotic recombination intermediates and is required for checkpoint arrest when breaks persist.
What is the role of Pch2 in the meiotic recombination checkpoint?
Pch2 has a nucleolar-independent role in the meiotic recombination checkpoint and localizes to meiotic chromosomes in a checkpoint-controlled manner.
Does the meiotic recombination checkpoint prevent DNA rereplication?
Yes, a meiotic recombination checkpoint response prevents DNA rereplication during meiotic prophase.
Is there a mechanical checkpoint in oocytes?
Yes, a Piezo-dependent checkpoint at the oocyte nuclear envelope links mechanical signals to meiotic progression in mouse oocytes.
Which diseases are linked to meiotic recombination checkpoint defects?
Defects are linked to aneuploidy, infertility and genome instability, and many checkpoint components are relevant to cancer.
How do researchers study meiotic recombination checkpoint signaling?
They use yeast genetics, tagged knock-in imaging, phospho-proteomics, CRISPR library screening and oocyte live imaging.
Can CRISPR models help study GO:0051598?
Yes, knockout, point-mutation, knock-in and overexpression models can test gene function, regulation and localization in the checkpoint pathway.
Conclusion
GO:0051598, meiotic recombination checkpoint signaling, is a conserved surveillance pathway that couples the completion of recombination to the decision to segregate homologous chromosomes during late prophase I. Its core machinery includes ATM/ATR-related kinases, the 9-1-1 clamp, Ddc2/ATRIP, CHK kinases and Pch2/TRIP13, and it also prevents DNA rereplication and integrates mechanical signals at the oocyte nuclear envelope. Defects in this checkpoint cause aneuploidy, infertility and genome instability, making it a key area for reproductive and cancer research. With precise CRISPR models and screening services, EDITGENE supports researchers in dissecting the genes, residues and regulatory inputs that control this essential meiotic checkpoint.
References
- 1. Raina VB et al.. 2023. Checkpoint control in meiotic prophase: Idiosyncratic demands require unique characteristics.. Curr Top Dev Biol 151:281-315 PMID: 36681474
- 2. Lydall D et al.. 1996. A meiotic recombination checkpoint controlled by mitotic checkpoint genes.. Nature 383(6603):840-3 PMID: 8893012
- 3. Refolio E et al.. 2011. The Ddc2/ATRIP checkpoint protein monitors meiotic recombination intermediates.. J Cell Sci 124(Pt 14):2488-500 PMID: 21693576
- 4. Liu C et al.. 2024. Chemically induced proximity reveals a Piezo-dependent meiotic checkpoint at the oocyte nuclear envelope.. Science 386(6724):eadm7969 PMID: 39571011
- 5. Herruzo E et al.. 2019. Characterization of Pch2 localization determinants reveals a nucleolar-independent role in the meiotic recombination checkpoint.. Chromosoma 128(3):297-316 PMID: 30859296
- 6. Najor NA et al.. 2016. Prevention of DNA Rereplication Through a Meiotic Recombination Checkpoint Response.. G3 (Bethesda) 6(12):3869-3881 PMID: 27678521
- 7. Subramanian VV et al.. 2014. The meiotic checkpoint network: step-by-step through meiotic prophase.. Cold Spring Harb Perspect Biol 6(10):a016675 PMID: 25274702
- 8. Kar FM et al.. 2021. Phospho-Regulation of Meiotic Prophase.. Front Cell Dev Biol 9:667073 PMID: 33928091
